donald j, fees and rates), biotech, covid, covid-19, customs (tariff), drugs (pharmaceuticals), eli lilly and company, food and drug administration, generic brands and products, glp-1 ras (drug), health, health insurance and managed care, healthcare, hi, international trade and world market, journalists, kennedy, media, news, novo nordisk a/s, obesity, pfizer inc, prices (fares, regulation and deregulation of industry, science, trump, united states politics and government, weight, clinical trials, united states, biden